Search results
Infusions for psoriatic arthritis: Purpose, medications, benefits
Medical News Today· 2 days agoInfusion therapy for psoriatic arthritis (PsA) involves administering medications known as biologics...
What's in a Name: Defining Difficult-to-Treat axSpA and PsA
Medscape· 13 hours agoDespite an expanding arsenal of disease-modifying antirheumatic drugs (DMARDs), many patients with...
Stopping the march: Can effective treatment of psoriasis prevent progression to psoriatic arthritis?
Medical Xpress· 2 days agoPsoriatic arthritis (PsA) is a chronic inflammatory arthritis which appears in around one-third of...
Exploring whether different joints have different treatment outcomes in cases of psoriatic arthritis
Medical Xpress· 2 days agoThere are many treatment options for psoriatic arthritis (PsA), and EULAR—The European Alliance of...
UCB to share first presentations of BIMZELX® (bimekizumab-bkzx) two-year data in axial...
Williamson Daily News· 2 days agoThe impact of BIMZELX treatment on two-year radiographic progression in the spine of patients with...
AbbVie and FutureGen link on inflammatory bowel disease
Pharmaceutical Technology via Yahoo Finance· 9 hours agoIn June 2024 AbbVie announced that its RINVOQ (upadacitinib) is now indicated for treating...
Sanibel Captiva Trust Company Inc. Takes Position in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 6 hours agoSanibel Captiva Trust Company Inc. bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought ...
Achieving drug-free remission in axial spondyloarthritis: Exploring the role of tight control in...
Medical Xpress· 21 hours agoEarly therapeutic interventions in inflammatory rheumatic diseases have proven successful in...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
Louisiana Illuminator via Yahoo News· 4 hours agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive via Yahoo Finance· 4 days agoBoth medicines are TYK2 inhibitors, a group of oral medicines that drugmakers are positioning as...